bosentan anhydrous has been researched along with Myelodysplastic Syndromes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonilla-Palomas, JL; Gámez-López, AL; López-Ibáñez, MC; Moreno-Conde, M; Villar-Ráez, A | 1 |
1 other study(ies) available for bosentan anhydrous and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Effectiveness of bosentan in a case of pulmonary arterial hypertension associated with myelodysplastic syndrome.
Topics: Aged; Antihypertensive Agents; Bosentan; Drug Administration Schedule; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Myelodysplastic Syndromes; Sulfonamides; Treatment Outcome | 2014 |